E-LIB Suche - Ergebnisse für: Opolka-Hoffmann, Eugenia - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a n..:

Spreafico, Anna ; Couselo, Eva Muñoz ; Irmisch, Anja...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Biodistribution of Drug/ADA Complexes: The Impact of Immune..:

Opolka-Hoffmann, Eugenia ; Edelmann, Martin R. ; Otteneder, Michael B....
The AAPS Journal. 26 (2024) 2 - p. , 2024

Link: https://doi.org/10.1208/..

3

High Ionic Strength Dissociation Assay Reduces Dimeric Targ..:

Pöhler, Alexander ; Jany, Cordula ; Butzer, Joachim...
Bioanalysis. 15 (2023) 14 - p. 823-832 , 2023

Link: https://doi.org/10.4155/..

4

Enhanced immunogenic potential of cancer immunotherapy anti..:

Egli, Jerome ; Heiler, Stefan ; Weber, Felix...
mAbs. 14 (2022) 1 - p. , 2022

Link: https://doi.org/10.1080/..

5

The impact of immunogenicity on therapeutic antibody pharma..:

Opolka-Hoffmann, Eugenia ; Jordan, Gregor ; Otteneder, Michael...
mAbs. 13 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

6

Enhanced immunogenic potential of cancer immunotherapy anti..:

Jerome Egli ; Stefan Heiler ; Felix Weber...
https://www.tandfonline.com/doi/10.1080/19420862.2022.2143009. , 2022

Link: https://doi.org/10.1080/..

7

The impact of immunogenicity on therapeutic antibody pharma..:

Eugenia Opolka-Hoffmann ; Gregor Jordan ; Michael Otteneder...
https://www.tandfonline.com/doi/10.1080/19420862.2021.1995929. , 2021

Link: https://doi.org/10.1080/..

1-7